Rep. Julie Johnson Sells CME Group Inc. (NASDAQ:CME) Stock

Posted by Defense World Staff on Sep 19th, 2025

Representative Julie Johnson (D-Texas) recently sold shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on August 14th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Fidelity National Information Services (NYSE:FIS) on 8/14/2025.
Sold $1,001 – $15,000 in shares of ConocoPhillips (NYSE:COP) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 8/14/2025.
Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 8/14/2025.
Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/14/2025.

CME Group Trading Down 0.7%

NASDAQ CME opened at $260.59 on Friday. The firm has a market cap of $93.91 billion, a PE ratio of 25.23, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43. CME Group Inc. has a 1-year low of $212.38 and a 1-year high of $290.79. The stock has a 50-day moving average of $272.25 and a 200-day moving average of $270.52. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the firm earned $2.56 earnings per share. CME Group’s quarterly revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of several analyst reports. Barclays set a $298.00 target price on CME Group and gave the stock an “equal weight” rating in a report on Thursday, July 24th. Oppenheimer increased their price target on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. UBS Group reduced their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a report on Monday, September 8th. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Finally, Citigroup raised their price objective on shares of CME Group from $265.00 to $275.00 and gave the stock a “neutral” rating in a report on Thursday, July 3rd. Four research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $260.60.

Read Our Latest Stock Report on CME

Institutional Trading of CME Group

Large investors have recently bought and sold shares of the stock. Webster Bank N. A. grew its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the period. Highline Wealth Partners LLC boosted its holdings in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Wayfinding Financial LLC acquired a new stake in CME Group during the first quarter worth $25,000. Cornerstone Planning Group LLC increased its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Finally, Sagard Holdings Management Inc. purchased a new stake in CME Group in the second quarter valued at approximately $30,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.